Weill Cornell Medicine Oncology & Hematology
Playback speed
10 seconds
Tailoring Therapies to Target Leukemia Stem Cells: PU-FITC Binding Assay Could Be Utilized to Select Patients That Are More Likely to Respond to Treatment With PUH71
12 views
May 14, 2020
Login to view comments.
Click here to Login
Videos